BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 29, 1999
View Archived Issues
Deltagen and Pfizer establish target validation agreement
Read More
Abgenix: year-end 1998 highlights
Read More
Antex Biologics successfully completes phase I study of Helicobacter vaccine
Read More
Neotrofin shows positive results in phase II trial for Alzheimer's disease
Read More
Medtronic and Sofamor Danek finalize merger
Read More
Abgenix and Genentech form new antibody collaboration
Read More
Broad-spectrum antibacterial agents discovered at Daiichi
Read More
Nippon Soda discloses new series of inhibitors of cholesterol biosynthesis
Read More
New cardiac antiischemic agents developed by Lederle in Japan
Read More
Cytokine inhibitors from Merck presented in recent patent literature
Read More
Newly patented antiproliferative agents selectively inhibit protein farnesyltransferase
Read More
Medarex's first HuMAb-Mouse-derived antibody enters the clinic
Read More
U.K. launch announced for hemophilia B treatment
Read More
Japanese researchers describe amidine compounds for eating disorders
Read More
Agouron R&D products will round out Warner-Lambert's pipeline
Read More
Antipsychotic development candidate selected from carbazolone series by Spanish scientists
Read More
Proteasome inhibitors may have potential in refractory CLL
Read More
Temodal receives E.U. approval for recurrent gliobastoma multiforme
Read More
FDA advisory committee scheduled to discuss Relenza NDA
Read More
Medtronic and Arterial Vascular Engineering finalize merger
Read More
European Commission approves Betaseron for treatment of SPMS
Read More
InSite Vision licenses novel glaucoma treatment to Pharmacia & Upjohn
Read More
Canadian company formed to develop nucleic acid-based antiinfective drugs
Read More
Gliatech initiates ADCON-P pivotal clinical trial
Read More
Patent covering second-generation taxanes issues to Xechem
Read More
Abgenix initiates phase I trial with ABX-IL-8 in rheumatoid arthritis patients
Read More